The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1245 Weight Loss articles
Duke University researchers have developed a novel oral delivery system for GLP-1 medications that protects peptides from stomach acid, potentially eliminating the need for injections.
A recent national database study reveals significant obstetric risks associated with semaglutide exposure before and during pregnancy, highlighting the importance of the weight rebound effect.
Discover how GLP-1 medications, known for weight loss, may also significantly reduce the need for knee replacement surgery. This article delves into the latest research and its implications for joint health.
A groundbreaking pill developed by researchers at Karolinska Institutet and Stockholm University offers a new avenue for treating type 2 diabetes and obesity. Unlike injectable GLP-1 agonists, this oral medication targets muscle metabolism to enhance fat burning and improve blood sugar control, aiming to circumvent common side effects.
With the surge in demand for weight loss and diabetes medications, counterfeit drugs have become a critical safety concern. This guide details how to verify Ozempic batch numbers and protect your health.
Ozempic is a household name, but experts warn it isn't a magic bullet. Dr. Shilpa Verma discusses the essential lifestyle component required for sustainable weight loss.
As New Zealand considers public funding for Wegovy, experts warn that medication alone cannot solve the obesity epidemic driven by complex environmental and social factors.
Glenmark Pharmaceuticals outlines an ambitious FY27 growth strategy, highlighting significant expansion in the GLP-1 segment with GLIPIQ. Discover how this impacts global access to Semaglutide and weight loss therapies.
New data from EPIC Research highlights a correlation between rising GLP-1 prescriptions and a modest decline in US obesity rates, offering hope amidst ongoing challenges.
